Status:
UNKNOWN
Norwegian Occipital Ischemic Stroke Study
Lead Sponsor:
Haukeland University Hospital
Collaborating Sponsors:
Helse Stavanger HF
St. Olavs Hospital
Conditions:
Ischemic Stroke
Visual Field Defect
Eligibility:
All Genders
18+ years
Brief Summary
Patients who suffer an ischemic stroke in the occipital lobe often experience Visual Field defects. Visual Field defects are negatively correlated to falling, institutionalisation, rehabilitation outc...
Detailed Description
BACKGROUND: Visual Field defects after cerebral infarction is an increasingly acknowledged problem, which has consequences for patient outcome. The aim of the Norwegian Occipital Ischemic Stroke Study...
Eligibility Criteria
Inclusion
- Written consent obtained,
- age \>18,
- acute occipital infarction on brain imaging and ability to cooperate for examination with autoperimetry
Exclusion
- Pathological processes that severely affect eyesight.
Key Trial Info
Start Date :
August 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2016
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT02307981
Start Date
August 1 2013
End Date
June 1 2016
Last Update
August 19 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Stavanger University Hospital
Stavanger, Rogaland, Norway
2
St. Olav University Hospital
Trondheim, Norway